氯雷他定糖浆治疗小儿过敏性咳嗽78例疗效观察

The clinical observation 78 cases of loratadine syrup treating children's cough variant asthma

目的观察氯雷他定糖浆治疗小儿过敏性咳嗽的临床疗效。方法将156例过敏性咳嗽患儿随机分为治疗组和对照组,对照组给予基础治疗,治疗组给予基础治疗加氯雷他定糖浆治疗,比较两组疗效。结果治疗组总有效率为98.72%;对照组总有效率为57.69%,,治疗组疗效显著优于对照组(P<0.05)。结论在常规治疗基础上加用氯雷他定糖浆治疗小儿过敏性咳嗽,能明显提高临床疗效,值得临床推广。

Objective To observe the clinical curative effect of loratadine syrup treating children cough variant asthma. Methods 156 cases of children cough variant asthma were randomly divided into treatment group and control group, both groups give foundation treatment,the treatment group based on this add with loratadine syrup treatment, compare two sets of curative effect. Results The treatment group total effectiveness 98.72% ;The comparison group total effectiveness 57. 69%, the curative effect of treatment group was better than control group （P 〈 0. 05 ）. Conclusion Based on conventional treatment combined with loratadine syrup in treating children cough variant asthma, this obviously improve the clinical curative effect, and worth clinical promotion.